TheProfitWatch

VKTX - Viking Therapeutics, Inc

Day 1m 10m 60m PreMarket Market AfterHours Gap
33.76 0.56 (1.66%) -0.02 (-0.04%) -0.09 (-0.26%) -0.1 (-0.29%) 0.29 (0.86%) 0.29 (0.85%) -0.68 (-1.99%) -0.1 (-0.29%)

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.58
Diluted EPS:
-0.58
Basic P/E:
-59.1724
Diluted P/E:
-59.1724
RSI(14) 1m:
57.42
VWAP:
34.34
RVol:

Events

Period Kind Movement Occurred At

Related News